Pingora Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.55M Sell
89,410
-100
-0.1% -$2.66K 1.65% 16
2026
Q2
$2.16M Hold
89,510
– – 1.26% 17
2026
Q1
$2.51M Buy
89,510
+5,650
+7% +$150K 1.49% 12
2025
Q4
$2.09M Buy
83,860
+2,692
+3% +$67.9K 1.28% 13
2025
Q3
$2.07M Sell
81,168
-1,230
-1% -$30.4K 1.37% 13
2025
Q2
$2M Sell
82,398
-1,170
-1% -$27.3K 1.49% 14
2025
Q1
$2.12M Sell
83,568
-1,150
-1% -$30.1K 1.57% 10
2024
Q4
$2.25M Buy
84,718
+16,748
+25% +$454K 1.47% 10
2024
Q3
$1.97M Buy
67,970
+21,275
+46% +$621K 1.39% 9
2024
Q2
$1.31M Buy
46,695
+12,105
+35% +$333K 0.93% 22
2024
Q1
$960K Buy
34,590
+280
+0.8% +$7.77K 0.7% 30
2023
Q4
$988K Hold
34,310
– – 0.87% 29

Other funds holding PFE

Pingora Partners's PFE Position: Q3 2026 in Review

Pingora Partners reduced its Pfizer (PFE) stake by 0.11% in Q3 2026, selling an estimated $2.66K and leaving 89,410 shares worth $2.55M. The position accounts for 1.65% of the portfolio, ranked #16.

Pingora Partners first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Pingora Partners held 89,410 shares of Pfizer worth $2.55M as of Q3 2026.
  • Pingora Partners sold 100 Pfizer shares in Q3 2026, an estimated $2.66K.
  • Pfizer made up 1.65% of Pingora Partners's portfolio in Q3 2026, its #16 holding.
  • Pingora Partners first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
  • 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Pingora Partners's 13F filing for Q3 2026, filed 13 Nov 2026.